<DOC>
	<DOCNO>NCT01881386</DOCNO>
	<brief_summary>This project design investigate whether measurement lactate tumour , make use magnetic resonance technique similar MRI , effective non-invasive method detect whether new target drug desired effect . The study hypothesis use magnetic resonance spectroscopy technique , able observe change tumour lactate level vivo , response treatment .</brief_summary>
	<brief_title>Lactate Imaging Tumour Biomarker</brief_title>
	<detailed_description />
	<criteria>Cohort 1 : lymphoma patient minimum lesion size 2cm pretreated schedule treat CHOP ( Cyclophosphamide , Hydroxydaunomycin , Oncovin Prednisolone ) Cohort 2 : Colorectal patient metastatic disease least 2cm pretreated Cohort 3 : Phase 1 Drug Development minimum lesion size least 2cm Cohort 4 : Brain primary brain tumour receive radiotherapy temozolomide cerebral lymphoma receive standard chemotherapy MRI incompatible metal implant Claustrophobia Inability tolerate 40 minute MRI scan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Magnetic Resonance Spectroscopy</keyword>
	<keyword>Lactate</keyword>
</DOC>